---

$1.25

N/A ( 0% ) 266.9K

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2025-06-05	Buy	23321.00	Florin Daniel P
2024-08-22	Buy	14245.00	Williamson Steven S.
2024-06-26	Sale	-1184.00	Rose Geoffrey Beran
2024-06-05	Sale	-15216.00	Ferrari Richard
2024-06-05	Sale	-15216.00	Burns Thomas William
2023-12-27	Sale	-1184.00	Rose Geoffrey Beran
2023-12-22	Sale	-10000.00	French Glendon E. III
2023-12-05	Sale	-402.00	Lehman David Aaron
2023-12-05	Sale	-135.00	McKune John
2023-12-05	Sale	-396.00	Rose Geoffrey Beran